Medpace 

€319.7
116
-€0.1-0.03% Hari ini

Statistik

Harga Tertinggi Hari
319.7
Harga Terendah Hari
319.7
52M Tertinggi
-
52M Terendah
-
Volum
0
Volum Purata
-
Kapasiti Pasaran
9.84B
Nisbah P/E
33
Pendapatan Dividen
-
Dividen
-

Akan Datang

Pendapatan

21OctDijangka
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Seterusnya
2.31
2.54
2.77
3
EPS yang dijangka
2.5254798961800002
EPS sebenar
N/A

Orang Lain Juga Mengikuti

Senarai ini berdasarkan senarai pantau orang di Stock Events yang mengikuti 01P.F. Ini bukan cadangan pelaburan.

Peserta

Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ini bukan cadangan pelaburan.

Mengenai

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Show more...
CEO
Dr. August James Troendle M.D.
Pekerja
5800
Negara
US
ISIN
US58506Q1094
WKN
000A2APTV

Penyenaraian